Monoclonal antibody RFT5-ricin chain A conjugate
Latest Information Update: 24 Apr 2002
At a glance
- Originator Nonindustrial source
- Class Antineoplastics; Drug conjugates; Immunotoxins; Monoclonal antibodies
- Mechanism of Action Protein synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Hodgkin's disease
Most Recent Events
- 20 Jul 2000 New profile
- 20 Jul 2000 Preclinical development for Hodgkin's disease in Germany (Unknown route)